Skip to main content
Caplight Logo









Qihan Biotech

Qihan Biotech

Private
HangzhouHealthcare & Life Scienceshttps://www.qihanbio.com/

Last Round

VC Round

Sep 22, 2023

Total Funding Raised

$100.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Qihan Biotech is a biotechnology company that develops off-the-shelf cell therapies and xenogeneic organs using multiplex genome editing technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T cell therapyallogeneic cell therapyxenotransplantationgene editingcell therapyoff-the-shelf therapymultiplex gene editingpig organ transplantgenome engineeringtransplantation immunologyxenogeneic organsautoimmune disease treatmentbiotechclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qihan Biotech Comparables

Compare Qihan Biotech with similar companies based on industry and business-model similarity.

Qihan Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neukio Biotherapeutics
85%
Adicet Bio
78%
Allogene Therapeutics
77%

Qihan Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 22, 2023
Series A ExtensionMar 29, 2021
Series A ExtensionSep 23, 2019
Series AJul 23, 2018

Qihan Biotech Investors

Notable investors and investment history

Qihan Biotech investors
InvestorRounds
MatrixVC Round, Series A Extension
Legend StarSeries A Extension
招银国际金融有限公司Series A Extension
BC PartnersSeries A Extension
ARCH Venture PartnersSeries A
Northern Light Venture CapitalSeries A, Series A Extension, VC Round
Biomatics Capital PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 300% MoM, reaching 2.1K.

  • Apr 16, 2026

    Monthly visitors increased 119% MoM, reaching 4.9K.

Qihan Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qihan Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qihan Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range15
Year Founded2017
Last FundingSep 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?